Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
2019 · Nature Communications · 256 citations
https://doi.org/10.1038/s41467-019-08782-1
W
Weiyi Peng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
341
Papers
9.7K
Citations
36
h-index
61
i10-index
Weiyi Peng is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & CAR-T cell therapy research & Melanoma and MAPK Pathways. The author has an h-index of 36, co-authored 290 publications.
ORCID: 0000-0002-7785-6240Papers by this author
worksPRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition
2023 · Cell Reports Medicine · 25 citations
https://doi.org/10.1016/j.xcrm.2023.101326
Melanoma and immunotherapy bridge 2015
2016 · Journal of Translational Medicine · 24 citations
https://doi.org/10.1186/s12967-016-0791-2
PPP2R1A mutations portend improved survival after cancer immunotherapy
2025 · Nature · 20 citations
https://doi.org/10.1038/s41586-025-09203-8
Lewy body dementia promotion by air pollutants
2025 · Science · 20 citations
https://doi.org/10.1126/science.adu4132
CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner
2017 · Oncogene · 10 citations
https://doi.org/10.1038/onc.2017.35
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat